Volume 6, Issue 4 (11-2019)
JROS 2019, 6(4): 25-30 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Valiollahi B, Salehpour M, Bashari H, Majdi S, Mohammadpour M. A Typical Metatarsal Fracture in a Patient on Long-Term Bisphosphonate Therapy. JROS 2019; 6 (4) :25-30
URL: http://jros.iums.ac.ir/article-1-2043-en.html
URL: http://jros.iums.ac.ir/article-1-2043-en.html
1- Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
Abstract: (1426 Views)
Bisphosphonates, more particularly alendronate, are a popular category of drugs in the treatment of postmenopausal and corticosteroid-induced osteoporosis. The present study contends that the long-term consumption of bisphosphonates causes not only subtrochanteric and femoral shaft fractures but also pathological fractures at other musculoskeletal sites. This report presents a rare case of alendronate-induced pathological metatarsal fracture in a 59-year-old female with a history of cuboid fracture following a twisting with abnormal Bone Mineral Density (BMD) (T score: −3.5; lumbar spine and −2.6; proximal femur).
Type of Study: Case Report |
Subject:
Knee surgery
Received: 2019/05/3 | Accepted: 2019/12/25 | Published: 2019/12/25
Received: 2019/05/3 | Accepted: 2019/12/25 | Published: 2019/12/25
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
